Cargando…
Catechol-O-methyltransferase Val158Met genotype and the clinical responses to duloxetine treatment or plasma levels of 3-methoxy-4-hydroxyphenylglycol and homovanillic acid in Japanese patients with major depressive disorder
PURPOSE: This study investigated the relationships among the plasma levels of catecholamine metabolites, the clinical response to duloxetine treatment, and Val158Met polymorphism of the catechol-O-methyltransferase (COMT) gene. SUBJECTS AND METHODS: Sixty-four patients and 30 healthy control subject...
Autores principales: | Atake, Kiyokazu, Yoshimura, Reiji, Hori, Hikaru, Katsuki, Asuka, Nakamura, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396648/ https://www.ncbi.nlm.nih.gov/pubmed/25897233 http://dx.doi.org/10.2147/NDT.S80953 |
Ejemplares similares
-
Duloxetine, a Selective Noradrenaline Reuptake Inhibitor, Increased Plasma Levels of 3-Methoxy-4-hydroxyphenylglycol but Not Homovanillic Acid in Patients with Major Depressive Disorder
por: Atake, Kiyokazu, et al.
Publicado: (2014) -
Serum levels of brain-derived neurotrophic factor (BDNF), proBDNF and plasma 3-methoxy-4-hydroxyphenylglycol levels in chronic schizophrenia
por: Yoshimura, Reiji, et al.
Publicado: (2016) -
Catechol-O-Methyltransferase Val158Met Polymorphism Is Associated with Somatosensory Amplification and Nocebo Responses
por: Wendt, Laura, et al.
Publicado: (2014) -
The Influence of the Val158Met Catechol-O-Methyltransferase Polymorphism on the Personality Traits of Bipolar Patients
por: Dávila, Wendy, et al.
Publicado: (2013) -
Catechol‐O‐methyltransferase Val158Met polymorphism associates with affect and cortisol levels in women
por: Hill, Lauren D., et al.
Publicado: (2018)